Bionovo Reports On Metabolic Studies Related To Its Menopausal Hot Flash Drug Candidate Bionovo, Inc. (Nasdaq: BNVI) announced the publishing of a paper in the journal for the American Society for Pharmacology and Experimental Therapeutics, Drug Metabolism and Disposition, entitled "Oxidative In Vitro Metabolism of Liquiritigenin, a Bioactive Compound Isolated from the Chinese Herbal Selective Estrogen Beta-Receptor Agonist MF101.
Source: www.medicalnewstoday.com
# posted by Network @ 9:00 PM
